Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5701461

O=C(O)C(F)(F)F.O=C(O)CF

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.40
ALDH1A1 P00352 4/20 0.36
CASP1 P29466 1/20 0.35
TSHR P16473 4/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EGLN1 Q9GZT9 2/20 0.33
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
THRB P10828 1/20 0.33
LMNA P02545 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
CES1 P23141 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
OR51E2 Q9H255 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL28083559 0.87 ACLY (0.33) ACLY
Trifluoroacetic Acid SCHEMBL28235039 0.86 ALDH1A1 (0.38) ACLYALDH1A1TSHRL3MBTL1THRB
Trifluoroacetic Acid SCHEMBL30657022 0.82
Trifluoroacetic Acid SCHEMBL2484766 0.82 ALDH1A1 (0.44) ACLYALDH1A1TSHRL3MBTL1THRB
Fluoroacetate SCHEMBL13651728 0.82
Fluoroacetate SCHEMBL78188 0.82
Trifluoroacetic Acid SCHEMBL7814389 0.82 ALDH1A1 (0.44) ACLYALDH1A1TSHRL3MBTL1THRB
Fluoroacetate SCHEMBL5908770 0.82
Trifluoroacetic Acid SCHEMBL474 0.82
Trifluoroacetic Acid SCHEMBL4598430 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109966242-A A kind of nanogel, preparation method and antitumor medicament-carried nano gel 中国科学院长春应用化学研究所 2019-07-05 CN claimed
CN-1406226-A Novel malonic acid derivatives, process for their preparation, their use as inhibitors of factor XA activity and pharmaceutical compositions containing them AVENTIS PHARMA GMBH (DE) 2003-03-26 CN claimed
CN-102762586-B Treatment peptide 莱特克斯生物制药股份有限公司 2016-10-05 CN disclosed
EP-1687279-A1 7- [4-(4-CHLOROBENZYLOXY) BENZENESULFONYL]-8-METHOXY-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINIUM MALEATE OR TOSYLATE AS ANTIPSYCHOTICS GLAXO GROUP LIMITED (GB) 2006-08-09 EP disclosed
WO-2005051916-A1 7-[4-(4-CHLOROBENZYLOXY) BENZENESULFONYL]-8-METHOXY-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINIUM MALEATE OR TOSYLATE AS ANTIPSYCHOTICS GLAXO GROUP LIMITED (GB) 2005-06-09 WO disclosed
CN-1406226-A Novel malonic acid derivatives, process for their preparation, their use as inhibitors of factor XA activity and pharmaceutical compositions containing them AVENTIS PHARMA GMBH (DE) 2003-03-26 CN disclosed